194 related articles for article (PubMed ID: 30505305)
1. Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host…but Also the Parasite.
Toledo A; Osorio R; Matus C; Martinez Lopez Y; Ramirez Cruz N; Sciutto E; Fragoso G; Arauz A; Carrillo-Mezo R; Fleury A
Front Immunol; 2018; 9():2652. PubMed ID: 30505305
[No Abstract] [Full Text] [Related]
2. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
Keiser PB; Nash TE
Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid use in neurocysticercosis.
Nash TE; Mahanty S; Garcia HH;
Expert Rev Neurother; 2011 Aug; 11(8):1175-83. PubMed ID: 21797658
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the blood-brain barrier in pigs naturally infected with Taenia solium, untreated and after anthelmintic treatment.
Guerra-Giraldez C; Marzal M; Cangalaya C; Balboa D; Orrego MÁ; Paredes A; Gonzales-Gustavson E; Arroyo G; García HH; González AE; Mahanty S; Nash TE;
Exp Parasitol; 2013 Aug; 134(4):443-6. PubMed ID: 23684909
[TBL] [Abstract][Full Text] [Related]
5. [Neurocysticercosis: report of three cases and recommendations of treatment].
Alvarez Rodríguez E; Torres-Gárate R; Gutiérrez Larráinzar A; Cabello J; Espinós Pérez D
An Med Interna; 2004 Aug; 21(8):382-6. PubMed ID: 15373721
[TBL] [Abstract][Full Text] [Related]
6. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
7. Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.
Cangalaya C; Zimic M; Marzal M; González AE; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004207. PubMed ID: 26658257
[TBL] [Abstract][Full Text] [Related]
8. Medical management of neurocysticercosis.
Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
[TBL] [Abstract][Full Text] [Related]
9. Immunopathology in Taenia solium neurocysticercosis.
Fleury A; Cardenas G; Adalid-Peralta L; Fragoso G; Sciutto E
Parasite Immunol; 2016 Mar; 38(3):147-57. PubMed ID: 26667781
[TBL] [Abstract][Full Text] [Related]
10. TNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.
Mahanty S; Orrego MA; Cangalaya C; Adrianzen MP; Arroyo G; Calcina J; Gonzalez AE; García HH; Guerra-Giraldez C; Nash TE;
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006059. PubMed ID: 29190292
[TBL] [Abstract][Full Text] [Related]
11. Anticysticercal treatment and seizures in neurocysticercosis.
Singh G; Sander JW
Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
[No Abstract] [Full Text] [Related]
12. Effect of Transforming Growth Factor-β upon Taenia solium and Taenia crassiceps Cysticerci.
Adalid-Peralta L; Rosas G; Arce-Sillas A; Bobes RJ; Cárdenas G; Hernández M; Trejo C; Meneses G; Hernández B; Estrada K; Fleury A; Laclette JP; Larralde C; Sciutto E; Fragoso G
Sci Rep; 2017 Sep; 7(1):12345. PubMed ID: 28955045
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
Jung-Cook H
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
[TBL] [Abstract][Full Text] [Related]
14. Cysticidal Therapy for Diffuse Parenchymal and Calcific Neurocysticercosis.
Agarwal A; Srivastava MVP; Gupta A; Rajan R; Garg A; Mishra B; Singh MB; Bhatia R; Vishnu VY
Am J Trop Med Hyg; 2020 Nov; 104(2):734-738. PubMed ID: 33236706
[TBL] [Abstract][Full Text] [Related]
15. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.
García HH; Del Brutto OH
Neurology; 1999 Oct; 53(7):1582-4. PubMed ID: 10534273
[TBL] [Abstract][Full Text] [Related]
16. Intramedullary spinal neurocysticercosis treated successfully with medical therapy.
Ahmed S; Paul SP
J Egypt Soc Parasitol; 2014 Dec; 44(3):661-4. PubMed ID: 25643507
[TBL] [Abstract][Full Text] [Related]
17. Neglected parasitic infections in the United States: cysticercosis.
Cantey PT; Coyle CM; Sorvillo FJ; Wilkins PP; Starr MC; Nash TE
Am J Trop Med Hyg; 2014 May; 90(5):805-809. PubMed ID: 24808248
[TBL] [Abstract][Full Text] [Related]
18. Current approaches to cysticidal drug therapy for neurocysticercosis.
Del Brutto OH
Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
[TBL] [Abstract][Full Text] [Related]
19. Possible association between Taenia solium cysticercosis and cancer: increased frequency of DNA damage in peripheral lymphocytes from neurocysticercosis patients.
Herrera LA; Ramirez T; Rodríguez U; Corona T; Sotelo J; Lorenzo M; Ramos F; Verdorfer I; Gebhart E; Ostrosky-Wegman P
Trans R Soc Trop Med Hyg; 2000; 94(1):61-5. PubMed ID: 10748903
[TBL] [Abstract][Full Text] [Related]
20. [Neurocysticercosis].
Tscherpel C; Gottschalk A; Meyding-Lamadé U; Fink GR; Burghaus L
Fortschr Neurol Psychiatr; 2015 Aug; 83(8):451-5. PubMed ID: 26327477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
